Moreover, LRIG3 expression is significantly higher in low-grade gliomas than in high-grade gliomas (grades III and IV), and LRIG3 upregulation suggests a better prognosis in malignant glioma patients (14). Here, LRIG3 is linked to central nervous system cancer.